Displaying 13 - 24 of 35
Metabolism, Alcohol & Toxicity

Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD's impact on metabolic health and quality of life – new evidence (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Takeda: "Alpha-1 antitrypsin deficiency (AATD) - Associated liver disease: More common than you may think" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Tools for early detection of metabolic risk in MAFLD

Webcasts
View
Metabolism, Alcohol & Toxicity

Insights from the SIRIUS project – a population-wide liver disease screening program in Slovakia

Webcasts
View
Metabolism, Alcohol & Toxicity

Early screening of metabolic risk – the pharmacists’ perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: "Global Liver Health Forum 2023" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

To what extent can HRQoL impact clinical outcomes in MAFLD?

Webcasts
View
Displaying 13 - 24 of 35